Baseline Neurocognitive Functioning in Children/Teenagers and Young Adults Treated for Central Nervous System Malignancies Prior to Proton Therapy [0.03%]
S Gaito,Y Wang,A France et al.
S Gaito et al.
Aims: Central nervous system (CNS) malignancies represent approximately 30% of all paediatric and teenage and young adult (TYA) solid tumours. With improving survival rates exceed 70% at 5 years, focus has shifted towards...
Impact of Adjuvant Systemic Therapy and Differences in Synchronous and Metachronous Bilateral Early Breast Cancer in Long-Term Outcome [0.03%]
术后系统治疗对早期乳腺癌长期疗效及同期和异时性双侧乳腺癌的影响
J J Jobsen,J van der Palen,H Struikmans et al.
J J Jobsen et al.
Aims: The aim of this study was twofold: to analyse the 20-year outcomes and differences of invasive synchronous bilateral breast cancer (SBBC) and invasive metachronous bilateral breast cancer (MBBC) and to determine the...
Complications Post Gastrostomy Insertion in Patients with Head and Neck Cancer: A Systematic Review [0.03%]
头颈癌患者胃肠造口术后的并发症：系统性回顾
A C Rogers,C L Blake,R Willims et al.
A C Rogers et al.
Aims: Percutaneous endoscopic gastrostomy (PEG) or radiologically inserted gastrostomy (RIG) placement can result in adverse events. The aim of this study was to update the systematic literature review on complications fo...
Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial [0.03%]
有关局灶性前列腺癌的TWO与五分数磁共振引导自适应放射治疗并以占主导目标区加强照射（DOTA-2）II期随机试验的中期急性毒性分析评论
R Romrattaphan,P Dankulchai,T Prasartseree et al.
R Romrattaphan et al.
Reducing Variation in Palliative Treatment for Oesophago-Gastric Cancer: Insights from the National Oesophago-Gastric Cancer Audit [0.03%]
英国国民食管胃癌登记处减少食管胃癌症姑息治疗差异的见解
O O&#x;Connor,A McDonell,M H Park et al.
O O&#x;Connor et al.
Patterns and Predictors of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Detected Local Recurrence Following Postprostatectomy Salvage Radiotherapy for Prostate Cancer [0.03%]
前列腺癌术后挽救放射治疗后前列腺特异性膜抗原正电子发射断层扫描/X线计算机体层成像检测到的局部复发模式及预测指标
N Dietrich,A Mesci,A Berlin et al.
N Dietrich et al.
Aim: Salvage radiotherapy (sRT) is an effective curative option for patients with biochemical recurrence following radical prostatectomy (RP). However, a subset of patients will develop local recurrence (LR) following tre...
CBCT-Guided Pencil Beam Scanning Proton Therapy for Moving Lung Tumours: PROMO Study- Standardised Workflow and Early Outcomes From a Consecutive Real-World Cohort [0.03%]
基于锥形束ct的铅笔束扫描质子治疗移动性肺肿瘤：PROMO研究-标准工作流程和连续真实世界队列的早期结果
S Chilukuri,S Sundar,R Kamath et al.
S Chilukuri et al.
Aims: This study aimed to describe and evaluate a standardised workflow for cone beam computed tomography (CBCT)-guided, motion-managed intensity-modulated proton therapy (IMPT) in non-small cell lung cancer (NSCLC), inte...
Healthcare Systems Data (HSD) to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of HSD and Trial-Reported Outcomes Within the Add-Aspirin Cancer Clinical Trial [0.03%]
利用英国健康医疗系统数据提高临床试验效率：在Add-阿司匹林癌症临床试验中对健康医疗系统数据和临床试验报告结果的前瞻性研究
A Macnair,D C Gilbert,M Nankivell et al.
A Macnair et al.
Aims: Healthcare systems data (HSD) can potentially improve the efficiency and costs of clinical trials (CTs) and reduce the burden of follow-up. To be used in CTs, HSD need to be accessible, accurate and complete. We com...
Does Overall Treatment Time Impact Toxicity and Clinical Outcomes After Magnetic Resonance Imaging-Guided Stereotactic Body Radiotherapy to the Prostate? An evaluation of the Multi-OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac Repository [0.03%]
整体治疗时间会影响磁共振引导立体定向体放射治疗前列腺的毒性及临床结局吗？来自基于MR-linac登记库的多因素评价研究
R L Westley,L A Daamen,F R Teunissen et al.
R L Westley et al.
Aims: Prostate stereotactic body radiotherapy (SBRT) can be delivered using magnetic resonance imaging-guided radiotherapy (MRgRT) with the aim of increased precision and reduced toxicity. The overall treatment time (OTT)...